preload
Nov 29

Which patients suitable for breast-conserving surgery?

Which patients suitable for breast-conserving surgery, specifically some consensus has been reached, mainly in the following points: First, the tumor size is usually less than 3 cm. Second, the tumor is located in the breast to the periphery, not in the central area, of course, in recent years for the tumor is located in the central area can also make breast-conserving. Third, we adopted the clinical examination or ultrasound examination, does not consider there is axillary lymph node metastases. Fourth, is the size of the breast should be large enough, that is the size of the breast tumor compared with the same, this ratio should be more appropriate, if the breasts are too small to relatively large mass to carry out breast-conserving can hardly be a better breast shape Such insurance milk is not much significance. The last area is the patient’s wishes, the patient is willing to breast-conserving This is a very important aspect.

Will not increase the risk of recurrence?

Breast-conserving surgery is some of the tumor and surrounding normal tissue removed, in the end cut the number of suitable, currently considered the edge of a centimeter away from the tumor can be, but we were still doing cutting edge of the main pathology of cancer cells, that is cutting edge is the negative. Done after breast-conserving surgery, but also make the appropriate treatment, including chemotherapy, radiotherapy and endocrine therapy. If the treatment appropriate and does not increase the risk of metastasis and recurrence.

Of course, patients with breast-conserving radiation therapy after surgery to be done, because in the past that do breast cancer is lymph node radiotherapy or lymph node metastasis in patients over more than three, if there breast-conserving surgery, no matter how the situation lymph node samples radiation therapy should be carried out, if not do radiation therapy will lead to local recurrence rate was greatly increased.

Neo-adjuvant chemotherapy can reduce the mass is, and if some people are not suitable for breast-conserving surgery, through the neo-adjuvant chemotherapy can be successful is to do breast-conserving surgery?

If the patient has a strong desire to protect milk, but not in compliance with several standards have just said, they can do first neo-adjuvant chemotherapy, if chemotherapy developed very effective in this patient, at the completion of three to four cycles of chemotherapy after the , tumor shrinkage greater than 50% or more, that let’s finally reached the standard breast-conserving state, or may consider breast-conserving. However, after neoadjuvant chemotherapy for breast conservation after local recurrence rate of patients suitable for breast conservation than the original state of the patient’s relapse rate is higher, it is reported is about 15%: 7% of the relationship.

Random Posts

    Leave a Reply

    Spam Protection by WP-SpamFree